31 results for Medicine

F
FDA approves Vepdegestrant?

FDA approves Vepdegestrant?

Yes

$50k Vol.
$0 Liq.
Ended
F
FDA approves Viridian Therapeutics' Veligrotug?

Yes

$15k Vol.
$0 Liq.
Ended
F
FDA approves Cingulate's Ctx-1301?

No

$11k Vol.
$0 Liq.
Ended
F
FDA approves Sanofi’s Subcutaneous Sarclisa?

No

$11k Vol.
$0 Liq.
Ended
F
FDA approves Sanofi's Dupixent?

Yes

$10k Vol.
$0 Liq.
Ended
F
FDA approves argenx's Vyvgart?

Yes

$10k Vol.
$0 Liq.
Ended
F
FDA approves Sanofi's Subcutaneous Sarclisa?

Yes

$9k Vol.
$0 Liq.
Ended
F
FDA approves AstraZeneca's Truqap (capivasertib)?

No

$7k Vol.
$0 Liq.
Ended
F
FDA approves Ionis' Olezarsen?

Yes

$7k Vol.
$0 Liq.
Ended
F
FDA approves Outlook Therapeutics' ONS-5010?

Yes

$7k Vol.
$0 Liq.
Ended
F
FDA approves Unicycive's Oxylanthanum carbonate?

No

$6k Vol.
$0 Liq.
Ended
F
FDA approves Arcalyst technology transfer?

No

$6k Vol.
$0 Liq.
Ended
F
FDA approves GSK & Spero Therapeutics' Tebipenem HBr?

Yes

$5k Vol.
$0 Liq.
Ended
F
FDA approves Viatris' low-dose estrogen weekly patch?

Yes

$5k Vol.
$0 Liq.
Ended
F
FDA approves Arcutis' Zoryve cream?

Yes

$5k Vol.
$0 Liq.
Ended
F
FDA approves Grace Therapeutics’ GTx-104?

No

$5k Vol.
$0 Liq.
Ended
F
FDA approves Corcept Therapeutics' Relacorilant?

Yes

$4k Vol.
$0 Liq.
Ended
F
FDA approves Camurus' Oclaiz?

No

$3k Vol.
$0 Liq.
Ended
F
FDA approves MannKind's Afrezza?

Yes

$3k Vol.
$0 Liq.
Ended
F
FDA approves AstraZeneca's Camizestrant?

No

$3k Vol.
$0 Liq.
Ended